Advertisement
Device Sectors
Subscribe to Device Sectors
View Sample

FREE Email Newsletter

Reportlinker Adds ENT Devices Market Outlook in Brazil to 2017 - Hearing Aid Devices and Implants and Diagnostic Devices

April 14, 2011 4:33 am | by Bio-Medicine.Org | News | Comments

NEW YORK, April 14, 2011 /- Reportlinker.com announces that a new market research report is available in its catalogue: ENT Devices Market Outlook in Brazil to 2017 - Hearing Aid Devices and Implants and Diagnostic Devices...

Reportlinker Adds Neurology Devices Market Outlook in United States to 2017 - Neurostimulation Devices, Interventional Neurology and Others

April 14, 2011 3:33 am | by Bio-Medicine.Org | News | Comments

NEW YORK, April 14, 2011 /- Reportlinker.com announces that a new market research report is available in its catalogue: Neurology Devices Market Outlook in United States to 2017 – Neurostimulation Devices, Interventional Neurology and Others...

Reportlinker Adds ENT Devices Market Outlook in China to 2017 - Hearing Aid Devices and Implants and Diagnostic Devices

April 14, 2011 3:33 am | by Bio-Medicine.Org | News | Comments

NEW YORK, April 14, 2011 /- Reportlinker.com announces that a new market research report is available in its catalogue: ENT Devices Market Outlook in China to 2017 - Hearing Aid Devices and Implants and Diagnostic Devices...

Advertisement

Reportlinker Adds Pancreatic Cancer Therapy Area Pipeline Report

April 14, 2011 2:36 am | by Bio-Medicine.Org | News | Comments

NEW YORK, April 14, 2011 /- Reportlinker.com announces that a new market research report is available in its catalogue: Pancreatic Cancer Therapy Area Pipeline Report http://www.reportlinker.com/p0472369/Pancreatic-Cancer-Therapy-Area-Pipeline-Report.html The Pancreatic Cancer Therapy...

Reportlinker Adds Macular Degeneration Therapy Area Pipeline Report

April 14, 2011 2:36 am | by Bio-Medicine.Org | News | Comments

NEW YORK, April 14, 2011 /- Reportlinker.com announces that a new market research report is available in its catalogue: Macular Degeneration Therapy Area Pipeline Report http://www.reportlinker.com/p0472337/Macular-Degeneration-Therapy-Area-Pipeline-Report.html The Macular Degeneration...

More Do-It-Yourself Medical Tests

April 13, 2011 8:32 pm | by Massachusetts Institute of Technology | News | Comments

A startup thinks it can make at-home tests more useful to patients and doctors.

Penumbra Coil 400 by Penumbra Inc.: Class 1 Recall - Premature Detachment of the Coil(2)

April 13, 2011 3:31 pm | by U.S. Food & Drug Administration | News | Comments

Premature detachment of the coil may cause the coil to unintentionally migrate. This can lead to serious injury including blood clots and stroke.

Axxent FlexiShield Mini by iCAD (formerly Xoft Inc.): Recall- Product May Shed Particles of Tungsten

April 13, 2011 2:30 pm | by U.S. Food & Drug Administration | News | Comments

After use for IORT in breast tissue, these particles can be mistaken for suspicious calcifications during follow up X-rays or scans.

Advertisement

RECOVER Analyses Highlighted Need to Address Motor, Sleep and Other Non-Motor Symptoms of Parkinson's Disease

April 13, 2011 11:37 am | by Bio-Medicine.Org | News | Comments

BRUSSELS, April 13, 2011 /- New rotigotine data shown in four poster presentations at the 63rd Annual Meeting of the American Academy of Neurology (AAN) in Hawaii, U.S., highlighted the importance in Parkinson's disease (PD) of addressing both motor- and non-motor symptoms, such as sleep....

Tissue Engineering Shows Promise to Revolutionize Transplant Medicine

April 13, 2011 11:36 am | by Bio-Medicine.Org | News | Comments

SAN DIEGO, April 13, 2011 /- The engineering of replacement tissue shows promise to dramatically impact the treatment of patients with end stage heart failure.  While the field is still in early stages, researchers will discuss the potential for a revolutionary change in medicine at...

ThermoGenesis Announces Registration of Res-Q in India; Commercial Sales Expected to Begin in Current Quarter

April 13, 2011 9:38 am | by Bio-Medicine.Org | News | Comments

RANCHO CORDOVA, Calif., April 13, 2011 /- ThermoGenesis Corp. (NASDAQ: KOOL ), a leading supplier of innovative products and services that process and store adult stem cells, said today that its Res-Q™60 BMC System (Res-Q) has been registered by the Central Drugs Standard Control...

Delcath Receives Notice of European Regulatory Approval for Hepatic CHEMOSATâ„¢ Delivery System

April 13, 2011 9:38 am | by Bio-Medicine.Org | News | Comments

NEW YORK, April 13, 2011 /- Delcath Systems, Inc. (NASDAQ: DCTH ) today announced that the Company has been notified of CE Mark approval for its proprietary Hepatic CHEMOSAT™ Delivery System. The product has been approved with an indication for the percutaneous intra-arterial...

Talyst Signs Vendor Agreement With H. D. Smith to Provide Quality- and Patient Safety-Enhancing Pharmacy Automation Solutions

April 13, 2011 8:37 am | by Bio-Medicine.Org | News | Comments

BELLEVUE, Wash., April 13, 2011 /- Talyst, Inc. , a leader in pharmacy automation, announced a vendor agreement with H. D. Smith, the fourth largest national pharmaceutical wholesaler, to provide the Company with leading pharmacy automation technology for its acute and extended care...

Advertisement

DOD grant prompts Marinus' Fragile X drug trial

April 13, 2011 8:35 am | by Mass High Tech: The Journal of New England Technology | News | Comments

The lead drug candidate of Marinus Pharmaceuticals Inc., a Branford, Conn.-based company focused on therapeutic developments for central nervous system disorders, is the target of a $3 million grant awarded by the U.S. Department of Defense to study treatment for Fragile-X syndrome.

CareFusion Will Host an Earnings Conference Call on May 5 to Discuss the Results for the Third Quarter Fiscal 2011

April 13, 2011 8:33 am | by Bio-Medicine.Org | News | Comments

SAN DIEGO, April 13, 2011 /- CareFusion Corporation (NYSE: CFN ), a global leading medical technology company, today announced plans to release third quarter fiscal 2011 results on Thursday, May 5 following the close of trading on the New York Stock Exchange. The company will host a...

NeoStem's Subsidiary Progenitor Cell Therapy Receives FACT Accreditation for Its New Allendale, New Jersey Manufacturing Facility

April 13, 2011 6:36 am | by Bio-Medicine.Org | News | Comments

ALLENDALE, N.J., April 13, 2011 /- Progenitor Cell Therapy (PCT), a wholly owned subsidiary of NeoStem, Inc. (NYSE Amex: NBS ) and an internationally recognized cell therapy services and development company, announced today that it has, once again, demonstrated compliance with the...

Medical Device Industry Veteran Angela Horacek Joins AlloSource as VP of Operations

April 13, 2011 6:35 am | by Bio-Medicine.Org | News | Comments

CENTENNIAL, Colo., April 13, 2011 /- AlloSource, one of the nation's largest non-profit providers of skin, bone and soft tissue allografts for use in surgical procedures and the world's largest processor of live cellular bone growth substitutes, today announced the hire of Angela Horacek...

New Clinical Studies Reinforce the LAP-BAND® System is a Safe and Effective Weight-Loss Treatment for Obese Adults with Obesity-Related Comorbid Conditions

April 13, 2011 5:36 am | by Bio-Medicine.Org | News | Comments

IRVINE, Calif., April 13, 2011 /- Two new studies published in the current issue of Surgery for Obesity and Related Diseases, a peer-reviewed journal, add to the large body of scientific evidence which supports that the LAP-BAND® Adjustable Gastric Banding System, made by Allergan,...

ConvaTec Supported Studies to be Presented at the 24th Annual Symposium on Advanced Wound Care (SAWC) and Wound Healing Society (WHS)

April 13, 2011 5:36 am | by Bio-Medicine.Org | News | Comments

DALLAS, April 13, 2011 /- ConvaTec, a world-leading developer and marketer of innovative medical technologies for community and hospital care, today announced that data related to wound management will be presented at the 24th Annual Symposium on Advanced Wound Care and Wound Healing...

Taris Biomedical rounds up $18.3M in Series B financing

April 13, 2011 5:35 am | by Mass High Tech: The Journal of New England Technology | News | Comments

Taris Biomedical, a Lexington life sciences company developing combination drug-device products and co-founded by Michael Cima and Robert Langer, has taken in $18.3 million in a Series B funding round led by new investor Third Rock Ventures.

GE Healthcare Presents Interim Data on the Impact of DaTscanâ„¢ (Ioflupane I 123 Injection) SPECT Imaging on the Diagnosis and Clinical Management of Patients with Clinically Un...

April 13, 2011 5:33 am | by Bio-Medicine.Org | News | Comments

HONOLULU, April 13, 2011 /- Today, GE Healthcare announced interim results of a recently completed randomized study of the impact of DaTscan™ SPECT imaging on the clinical  management and diagnosis of adult patients who exhibit signs or symptoms of parkinsonian syndromes (PS)....

Medyssey Spine Receives 510(k) Clearance for Its LP Cage(TM) Posterior Lumbar Interbody Fusion System

April 13, 2011 3:37 am | by Bio-Medicine.Org | News | Comments

CHICAGO, April 13, 2011 /- Medyssey Co., Ltd., the parent company of Medyssey Spine , a spinal implant manufacturer focused on commercializing products for the surgical treatment of spine disorders, today announced that the Company has received 510(k) clearance from the FDA for its LP...

According to the Journal of Advanced Nursing, RyMed Technologies' InVision-Plus® Excels at Minimizing Bacterial Growth In Vitro

April 13, 2011 3:34 am | by Bio-Medicine.Org | News | Comments

FRANKLIN, Tenn., April 13, 2011 /- In the Journal of Advanced Nursing March issue, a comparative research evaluation of five needleless I.V. connectors tested by an independent laboratory showed that the RyMed InVision-Plus® (RYM-5001®) zero displacement connector best protected...

Investigational Drug May Reduce Involuntary Movements in People With Parkinson's Disease

April 12, 2011 12:36 pm | by Bio-Medicine.Org | News | Comments

HONOLULU, April 12, 2011 /PRNewswire-USNewswire/ -- Results of the first randomized, placebo-controlled long-term clinical trial show the investigational drug safinamide may reduce dyskinesia or involuntary movements in mid-to-late stage Parkinson's disease. The findings will be presented...

Novartis Drug Afinitor® Recommended by FDA Oncology Advisory Committee for Approval to Treat Advanced NET of Pancreatic Origin

April 12, 2011 11:36 am | by Bio-Medicine.Org | News | Comments

EAST HANOVER, N.J., April 12, 2011 /- Novartis Pharmaceuticals Corporation ("Novartis") announced today that the US Food and Drug Administration (FDA) Oncologic Drugs Advisory Committee (ODAC) recommended approval of Afinitor® (everolimus) tablets for the treatment of patients with...

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading